Naloxone 40 jig was administered intravenously one minute after birth to 20 out of 44 neonates whose mothers had been given pethidine in labour. These neonates were compared with 20 others whose mothers had had only lumbar epidural block. Alveolar PCO,, alveolar ventilation, and ventilatory rate were measured 10 and 30 minutes after birth. The untreated neonates of mothers who had had pethidine showed significant ventilatory depression compared with infants in the epidural and naloxone-treated groups. The naloxone-treated neonates were comparable with the epidural group, although the effects of naloxone were diminishing at 30 minutes. Naloxone is an effective narcotic antagonist which should be considered to be the drug ofchoice for treating narcotic depression in the neonate.
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Introduction

Method
Maternal consent for the investigation was obtained. Mature healthy neonates (38-42 weeks) delivered spontaneously or by easy forceps delivery whose mothers received pethidine during labour were randomly allocated to receive either naloxone (pethidine-naloxone group) or no treatment (pethidine group). Naloxone, 40 Ig in 1-3 ml of water, was injected into the umbilical vein one minute after birth; this dose was based on adult doses. These neonates were compared with those whose mothers had had analgesia only by continuous lumbar epidural block using bupivacaine hydrochloride 0 5% without adrenaline (epidural group).
The time to first breath, the time of onset of sustained ventilation, and the Apgar score at one and five minutes;were recorded. Ten and 30 minutes after birth the alveolar Pco2 was measured by rapid infrared analysis of the expired gas, continuously sampled through a nasal catheter. Carbon dioxide excretion was measured by entraining expired gas in a steady air flow drawn through a gently applied facemask. The carbon dioxide concentration of the gas flow was continuously measured by an infrared carbon dioxide analyser; the output signal of the analyser was electronically integrated to provide a measure of carbon dioxide excretion. Alveolar ventilation was calculated, after appropriate corrections, from the alveolar Pco2 and the rate of carbon dioxide excretion.4 Alveolar Pco2 and carbon dioxide excretion were measured sequentially in 30-second periods. Ventilatory rate was recorded.
The plasma pethidine concentration of umbilical venous blood was measured by gas chromatography.
Statistical analysis was performed using Student's t test or, when appropriate, the Mann-Witney U test.5
Results
Sixty-four neonates were studied. Forty-four were delivered to mothers who had received pethidine, and 20 of these received naloxone. The mean (SD) dose of pethidine administered to the mothers was venous blood was 1-04 (0-44) ,umol/l (25 7 (10 9) ,Lg/100 ml) in the pethidine-naloxone group and 0 84 (0 48) tsmol/I (20 8 (11-9) jg/100 ml) in the pethidine group.
The mean weights of neonates in the pethidine-naloxone, pethidine, and epidural groups were similar: 3 25 (0 45) kg, 3 32 (0 54) kg, and 3-36 (0-39) kg respectively.
At one minute the mean Apgar score in the pethidine-naloxone group was similar to that in the pethidine group and lower than that in the epidural group (P = 0.02) (table I). The difference between the pethidine and epidural groups was not statistically significant (P = 0 12). At five minutes the Apgar scores were similar in the three groups. pethidine-naloxone and pethidine groups were similar and were longer than that in the epidural group (P = 0-002 and P = 0-04 respectively). Initially, therefore, ventilation in both pethidine groups was similarly depressed compared with that in the epidural group.
VENTILATORY MEASUREMENTS
At 10 minutes the mean alveolar Pco2 was lowest in the epidural group and highest in the pethidine group (P = 0008) (fig 1) . The alveolar Pco2 of the pethidine-naloxone group was close to that of the epidural group and also significantly less than that of the pethidine group (P = 0 03). At 30 minutes the alveolar Pco, of all three groups had fallen significantly (P < 0-01 for the three groups). The alveolar Pco2 of the pethidine-naloxone group was still lower than that of the pethidine group (P = 0-07) but higher than that of the epidural group (P = 0 03). The values in the pethidine and epidural groups were also significantly different (P = 0005).
At 10 and 30 minutes the alveolar ventilation was highest in the epidural group and lowest in the pethidine group; at 30 minutes this difference was significant (P = 004). The alveolar ventilation of the pethidine-naloxone group was intermediate. The ventilatory rate reflected these changes but none of the differences reached statistical significance.
The times to first breath of the pethidine-naloxone and pethidine groups were similar but both were longer than that in the epidural group (P = 0-02). The times to the onset of sustained ventilation of the 
Discussion
Although the influence of maternal analgesia on Apgar scores and onset of ventilation has been studied, the influence of analgesia on early neonatal ventilation has not been examined in detail. Ten and 30 minutes after birth the untreated neonates whose mothers received pethidine during labour had a higher alveolar Pco,, a lower alveolar ventilation, and a lower ventilatory rate than the neonates of the mothers who received no narcotics.
The neonates in both pethidine groups had comparable umbilical pethidine concentrations, Apgar scores, and times of onset of ventilation. Indeed, the pethidine-naloxone group was at a slight disadvantage. Nevertheless, the intravenous administration of 40 pg naloxone to the neonate one minute after birth produced a substantial difference in ventilatory function, the most obvious change being a lower alveolar Pco2. Clearly naloxone is an effective narcotic antagonist, reversing the ventilatory depressant effects of maternally administered pethidine. Only healthy neonates were studied so that ventilatory change could not be ascribed to intrapartum hypoxia or unfavourable delivery. Since naloxone has no agonist activity, unlike nalorphine or levallorphan, it can be safely given to any neonate believed to be suffering from narcotic-induced depression.
A single intravenous dose of naloxone has a short duration of action in the adult.2 Thirty minutes after birth there was some indication that the effect of naloxone was diminishing. The depressed neonate who has been treated with intravenous naloxone should therefore be kept under careful observation in There was no significant difference in the peak levels or pattern of enzyme increase. The incidence of cardiac failure and reinfarction was similar in the two groups, but major arrhythmias were less common in those on streptokinase (P <0 05). In the streptokinase group there were 36 minor and six more serious haemorrhagic com-
